EMA/WHO hatch plan to speed approvals in developing countries
This article was originally published in Scrip
Executive Summary
The World Health Organization and the European Medicines Agency are to take part in a pilot project intended to make it easier for medicines authorized for marketing in Europe to be licensed in developing countries where regulators may not have all the resources needed to operate their key regulatory functions.
You may also be interested in...
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.